Ikemoto, Fumihiko <br/><br/>
[Rizatriptan (Maxalt), a new entity of triptan for migraine: pharmacology and therapeutic relevance].  [electronic resource] 

 -  Nihon yakurigaku zasshi. Folia pharmacologica Japonica  Apr 2004 
 - 295-302 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article; Review 
<br/><br/><label>ISSN: </label>0015-5691 
<br/><br/><label>Standard No.: </label>10.1254/fpj.123.295  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Humans<br/>Meningeal Arteries--metabolism<br/>Migraine Disorders--drug therapy<br/>Quality of Life<br/>Receptor, Serotonin, 5-HT1B--physiology<br/>Receptor, Serotonin, 5-HT1D--physiology<br/>Serotonin 5-HT1 Receptor Agonists<br/>Tablets<br/>Triazoles--administration & dosage<br/>Trigeminal Nerve--metabolism<br/>Tryptamines